ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1625

Severe Infection Prior to Diagnosis of Systemic Lupus Erythematosus (SLE) Is Associated with Disease-Specific Attributes and Long-Term Comorbidities

Yu Deng 1, Anh Chung 2, Abel Kho 1, Yuan Luo 1, Rosalind Ramsey-Goldman 2 and Theresa Walunas2, 1Northwestern University, Chicago, 2Northwestern University, Chicago, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Disease Sub-phenotyping, disease susceptibility and informatics, Electronic Health Record, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Clinical Poster II: Comorbidities

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus is a systemic autoimmune disease whose mechanism of development is largely unknown. Prior infection is a suspected sentinel event that may trigger disease in susceptible people and have an impact on disease development. In this exploratory study, we investigated if severe infections prior to SLE diagnosis were associated with specific SLE attributes and comorbidities.

Methods: We identified 469 patients with known SLE in a physician validated registry, the Chicago Lupus Database, with medical records in the Northwestern Medicine Enterprise Data Warehouse (NMEDW). Each patient was assessed for the Systemic Lupus International Collaborating Clinics classification (SLICC) criteria, via chart review, to determine the presence or absence of each criteria. We excluded ANA from the analysis because 15% patients had missing ANA values (likely due to tests being performed at an outside institutions). Prior severe infections (viral, bacterial, fungal and mycobacterial) and comorbidities (heart failure, stroke, sepsis, end stage renal disease and osteoporosis) were identified based on ICD9/10 codes in the NMEDW. The association between prior infections and SLE criteria and comorbidities were evaluated using multivariate logistic regression.  Models were adjusted for age of SLE onset, sex and race/ethnicity.  Severe viral and bacterial infections were also analyzed separately in relation to criteria and comorbidities to assess associations.

Results: Among 469 patients, 26% had severe infections prior to SLE diagnosis, including 71 with viral infections and 49 with bacterial infections. The average age of SLE diagnosis in our population is 30.1 years; 50% are white, 29% African American, 21% identified in other racial/ethnic categories; 92% are female. For SLE comorbidities, 14% developed heart failure, 15% had a stroke, 9% developed ESRD, and 58% developed osteoporosis.  Association coefficients and p-values between infection prior to diagnosis of SLE and classification criteria are shown in Tables 1a and 1b and the relation between infections and comorbidities are shown in Table 2. Among classification criteria, prior infection is significantly associated with leukopenia (p=0.03). Among comorbidities, prior infection is significantly associated with heart failure and sepsis. When analyzing prior infections by viral and bacterial subgroups, bacterial infections had significant association with stroke (p=0.02) and sepsis (p= 0.004). Viral infections were significantly associated with oral ulcers (p=0.02) and sepsis (p= 0.009). Association between prior bacterial infection and alopecia (p= 0.07), serositis (0.06), as well as association between prior viral infection and leukopenia (p = 0.08) had borderline significance.

Conclusion: Our exploratory study shows severe infections prior to SLE diagnosis are associated with leukopenia, oral ulcers and an increased risk of heart failure, stroke and sepsis. These results suggest that prior infection could increase the likelihood of long term cardiovascular comorbidities, and that supportive care should be considered to minimize infections and cardiovascular complications for persons with SLE.


ACR2109.Table1a.Final.20190604

Table 1a: Association Between Prior Infections and Clinical SLICC Criteria


ACR2109.Table1b.Final.20190604

Table 1b: Association Between Prior Infections and Laboratory Based SLICC Criteria


ACR2109.Table2.Final.20190604

Table 2: Association Between Prior Infections and SLE Comorbidities


Disclosure: Y. Deng, None; A. Chung, None; A. Kho, Health Data Link, 4, 6; Y. Luo, None; R. Ramsey-Goldman, Exagen, 2; T. Walunas, Pfizer Inc., 5, Wyeth LLC, 5, Genetics Institute, LLC, 5, Merck KGaA, 5, EMD Serono, Inc, 5.

To cite this abstract in AMA style:

Deng Y, Chung A, Kho A, Luo Y, Ramsey-Goldman R, Walunas T. Severe Infection Prior to Diagnosis of Systemic Lupus Erythematosus (SLE) Is Associated with Disease-Specific Attributes and Long-Term Comorbidities [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/severe-infection-prior-to-diagnosis-of-systemic-lupus-erythematosus-sle-is-associated-with-disease-specific-attributes-and-long-term-comorbidities/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/severe-infection-prior-to-diagnosis-of-systemic-lupus-erythematosus-sle-is-associated-with-disease-specific-attributes-and-long-term-comorbidities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology